KMKYX
Price
$64.55
Change
+$0.49 (+0.76%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

KMKYX vs RPTIX

Header iconKMKYX vs RPTIX Comparison
Open Charts KMKYX vs RPTIXBanner chart's image
Kinetics Market Opportunities Inst
Price$64.55
Change+$0.49 (+0.76%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
KMKYX vs RPTIX Comparison Chart
Loading...
VS
KMKYX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMKYX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. KMKYX (184M). KMKYX pays higher dividends than RPTIX: KMKYX (0.87) vs RPTIX (0.18). KMKYX was incepted earlier than RPTIX: KMKYX (16 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. KMKYX (5.00). RPTIX has a lower initial minimum investment than KMKYX: RPTIX (500000) vs KMKYX (1000000). KMKYX annual gain was more profitable for investors over the last year : 52.32 vs. RPTIX (14.81). KMKYX return over 5 years is better than : 156.33 vs. RPTIX (15.09).
KMKYXRPTIXKMKYX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years9 years-
Gain YTD51.7409.127567%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets184M31.4B1%
Annual Yield % from dividends0.870.18482%
Returns for 1 year52.3214.81353%
Returns for 3 years63.55-13.57-468%
Returns for 5 years156.3315.091,036%
Returns for 10 years279.19N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp